-
Brefeldin A: From Trafficking to Translation
2026-08-24
Brefeldin A (BFA) is more than a vesicle transport inhibitor: it is a mechanistic probe for connecting ER-to-Golgi blockade with ER stress, cytoskeletal remodeling, apoptosis, and potentially endothelial barrier biology. This thought-leadership framework shows how translational researchers can use BFA with appropriate controls, evidence boundaries, and biomarker-oriented readouts.
-
Solanesol B8776: Practical Research Workflow
2026-08-24
Solanesol (B8776) provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, and exploratory enzyme or cell-based workflows. Its limited solubility requires DMSO-based stock preparation; it is insoluble in water and ethanol and is not intended for diagnostic, clinical, or medical use.
-
Central Opioid Circuits in Mechanical Hypersensitivity
2026-08-23
Yin et al. identify a brain-to-spinal μ-opioid circuit linking the lateral parabrachial nucleus, hypothalamic dynorphin neurons, and spinal dorsal horn GABAergic cells to morphine-induced mechanical hypersensitivity and analgesic tolerance. The study reframes these adverse effects as failures of central mechanical-pain gating and provides a circuit-level framework for testing receptor-specific interventions.
-
SN-38 Disrupts FUBP1–FUSE Binding
2026-08-22
The reference study identifies an additional action of camptothecin and SN-38: inhibition of the FUBP1 interaction with the single-stranded DNA element FUSE. By linking topoisomerase I inhibitor activity to transcriptional deregulation in hepatocellular carcinoma cells, the work provides a mechanistic basis for studying FUBP1 dependence in cancer models.
-
Rucaparib in DNA Damage Response Workflows
2026-08-22
Rucaparib (AG-014699) helps researchers connect PARP1 inhibition with persistent DNA damage, radiosensitization, and repair-deficient cancer phenotypes. This practical guide shows how to build, control, and troubleshoot assays that distinguish DNA repair failure from transcription-linked cell death.
-
MK-571: Reproducible Assay Design
2026-08-21
This scenario-based guide explains how MK-571 (L-660,711) can improve interpretation of cell viability, proliferation, and cytotoxicity experiments involving leukotriene signaling or MRP1 activity. It covers formulation, controls, protocol handling, mechanistic confounders, and vendor-selection considerations for SKU B7023.
-
CGI1746, σ1R, and Ferroptosis at MAMs
2026-08-20
The reference study identifies CGI1746 as a ferroptosis inhibitor that acts through the sigma-1 receptor at mitochondria-associated membranes. Its findings connect ER–mitochondria calcium transfer, mitochondrial reactive oxygen species, and PUFA-containing lipid handling to ferroptosis execution, creating a mechanistic framework for studying ferroptosis beyond iron metabolism and lipid synthesis.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic
2026-08-20
The Annexin V-Cy5/DAPI Apoptosis Kit turns phosphatidylserine exposure and membrane integrity into a time-resolved cell death map. This article connects that readout to P2RX1–CaMKII–PI3K/Akt biology in Ph+ ALL while emphasizing interpretation, controls, and assay selection.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-08-19
Turn mitochondrial depolarization into a quantitative red-to-green fluorescence ratio for apoptosis research, drug screening, and mitochondrial function analysis. This workflow shows how to apply the JC-1 Mitochondrial Membrane Potential Assay Kit to adherent cells, tissue mitochondria, and purified mitochondrial preparations while using CCCP controls to strengthen interpretation.
-
Filipin III: Reliable Membrane Cholesterol Workflows
2026-08-19
This scenario-based guide explains how Filipin III (SKU B6034) supports cholesterol detection in membranes, membrane cholesterol visualization, and interpretation of variable cell-assay results. It connects practical handling, experimental controls, and current immunometabolic literature without treating filipin staining as a substitute for viability or oxysterol-specific assays.
-
Protease Inhibitor Cocktail for LD Assays
2026-08-18
Learn how a Protease Inhibitor Cocktail can preserve labile DFCP1–ATGL complexes during lipid-droplet workflows. This guide connects inhibitor chemistry, EDTA compatibility, and assay design to more defensible mechanistic conclusions.
-
Bestatin (Ubenimex) Workflows for Cancer Research
2026-08-18
Bestatin (Ubenimex) supports targeted aminopeptidase activity measurement, multidrug resistance studies, and mechanistic cancer research. Its unexpected, matrix-dependent stimulation of endothelial invasion makes assay context, dose selection, and orthogonal controls essential.
-
How Human Mucus Shapes C. difficile Biology
2026-08-17
The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior at the epithelial interface. Its integrated transcriptomic, metabolic, biophysical, and dynamic measurements show that mucus is not merely a barrier: it can support growth, reshape metabolism, and promote biofilm-associated behavior.
-
Polybrene Workflows for Efficient Gene Delivery
2026-08-17
Learn how Polybrene can improve lentiviral, retroviral, and lipid-mediated DNA delivery while preserving cell health and assay interpretability. This practical guide also shows how controlled transduction can support mutant-p53 model development and chemical-induced-proximity assays.
-
Sulfo-NHS-SS-Biotin for Reversible Receptor Biology
2026-08-16
Sulfo-NHS-SS-Biotin enables reversible surface and protein labeling through an amine-reactive NHS ester and cleavable disulfide linker. This article explains how to deploy it as an assay-design tool for studying membrane-receptor proteostasis, using GABAA receptor biology to distinguish surface delivery, abundance, and function.